Related Experiment Video
Updated: Jan 10, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Dietary dipeptide γ-glutamyl valine (γ-EV) activates AMPK and improves glucose homeostasis in db/db mice
Bikram Upadhyaya1, Chia-Sin Liew2, Jean-Jack M Riethovan2
1Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA; Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA; NE Food for Health Center, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Abstract:
This study investigates the therapeutic potential of γ-glutamyl valine (γ-EV) in 4 week-old male db/db mice, a well-established model for type 2 diabetes. Mice were fed an AIN-93 G diet and administered γ-EV (500 mg/kg body weight) via drinking water for 3 weeks. Blood, liver, muscle, and intestinal tissues were collected to assess blood glucose, peptide bioavailability, liver function, glycogen levels, protein expression, and transcriptomic changes. γ-EV was bioavailable in circulation (2.07±1.59 μM) and significantly improved food efficiency (+79%, P<.0001), despite reduced calorie intake (-27%, P<.0001). Treated mice exhibited markedly reduced polyuria and water intake (-80%, P<.0001), and showed substantial reductions in blood glucose under both fasted (-76%, P<.0001) and non-fasted (-29%, P=.0054) conditions. Although γ-EV increased the hepatosomatic index (+66%, P<.0001), serum ALT levels remained unchanged (P=.0765), indicating no hepatotoxicity. RNA-seq revealed 1308 differentially expressed genes in the liver and 147 in the jejunum, with 26 genes overlapping between the two. Key upregulated GO terms included fatty acid metabolism (jejunum) and oxidoreductase activity (liver). Hepatic p-AMPKα levels increased (+86%, P=.0137) alongside decreased liver glycogen (-79%, P<.0001), suggesting γ-EV induces beneficial catabolic signaling. Overall, γ-EV shows promise as an anti-diabetic peptide.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
cAMP-dependent Protein Kinase Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cell Specific Gene Expression

